Public Calendar: February 2 - 8, 2025
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Sara Brenner, M.D., M.P.H., Acting Commissioner for Food and Drugs
No Significant Event
Official Name: Jim Jones, Deputy Commissioner for Human Foods
No Significant Event
Official Name: Ritu Nalubola, Ph.D., Acting Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Angelique Hebert, Acting Deputy Commissioner for Operations
No Significant Event
Official Name: Michael Rogers, Associate Commissioner for Inspections and Investigations
No Significant Event
Official Name: Jacqueline Corrigan Curay, J.D., M.D., Acting Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
No Significant Event
Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health
Event Date: 02/06/2025
Location: Silver Spring, MD
Subject: Device Safety Strategies
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several Philips representatives
Event Date: 02/07/2025
Location: Virtual
Subject: General Medical Device Updates
FDA Participant/Group: ROSS SEGAN; HEATHER DEAN; DAVID MCMULLEN; OWEN FARIS; ELLEN FLANNERY; ANGELA KRUEGER;
Non FDA Participant/Group: Jared Genser, Stephen Damianos (Perseus Strategies);
Official Name: Brian King, Ph.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine
No Significant Event
Official Name: Mark Raza, J.D., Chief Counsel
No Significant Event